|
Comprehensive program & exciting range of pre-conference workshops & seminars on Contract research industry, Clinical trials in variety of therapy areas, Research ethics & regulations, Drug development, Pharmaceutical medicine and Health economics
|
| Track: Keynote & Plenary |
Keynote address:
Clinical research in Malaysia |
Tan SriDato’ Seri Hj Dr Mohd Ismail Merican
Director-General of Health Malaysia |
| Plenary: Regulations & MOH guidelines for clinical research |
Dato’ Dr Maimunah A Hamid
Deputy Director- General of Health (R&TS)
MOH |
| Plenary: Globalization of Clinical Trials - Trends, Eff ects and Significances |
Prof Johan P.E. Karlberg Director, Clinical Trials Centre
The University of Hong Kong |
| Plenary: Pharmaceutical Medicine |
Dr Jean-Paul Deslypere SGS Life Science Services-Clinical Research |
| Track: Clinical research in Malaysia |
| The MOH Research Ethics Committee |
Dato’ Dr Chang Kian Meng Chair, Medical Research Ethics Committee |
| Funding for clinical research in financially challenging times |
Dr S. Asmaliza Ismail Head, NIH Secretariat, MOH/MREC |
| NPCB as a GLP Compliance Monitoring Authority for Malaysia |
Dr Kamaruzaman Saleh Head of Clinical Research & Compliance Section, National Pharmaceutical Control Bureau, MOH |
| Role of CIC in promoting clinical research in UMMC |
Prof Dr Rosmawati Mohamed, University Malaya Medical Centre UMMC |
| Role of CRC in promoting clinical research in HUSM |
Prof Dr Nor HayatiOthman Dean (Clinical Research Platf orm) UniversitiSains Malaysia |
| Role of CRC in promoting clinical research in UKMMC |
Prof Dr Rohaizak Muhammad Deputy Dean of Research and Industry University Kebangsaan Malaysia Medical Centre UKMMC, Chair UKM ethics committee |
| Conducting clinical trial in Malaysia: Pharma sponsors’ experience |
Dr Bernard Ng Medical Director, Sanofi-aventis |
| Sanofi-aventis Track: CRO industry in Malaysia |
| Role of CRC in promoting Malaysia to industry |
Dr Ong Loke Meng Head of CRC Hospital Pulau Pinang |
| Development of the CRO industry in Malaysia |
Mr Selvam Ramaraj Senior VP Healthcare, BiotechCorp Malaysia |
| Clinical Research Outsourcing: Opportunities and challenges |
Dr Anand Tharmaratnam CEO Quintiles SE Asia |
| Track: Drug development |
| Cancer genomics, biomarkers & drug development |
Dr Teo Soo-Hwang Chief Executive, Cancer Research Initiatives Foundation, CARIF |
| Virtual drug development |
Dr Christo van Niekerk CEO Global Alliance for TB Drug Development |
| Early phase studies: Does Malaysia have a chance? |
Dr Maurice Cross Director, Veeda Clinical Research UK |
| International GLP standards |
Dr Kumar Kurumaddali MalladiIndia |
| Tissue banking & drug development |
Dr Matt hew Lear Director of Strategic Alliances, Asterand US |
| Track: Off the beaten path |
| Breast cancer research |
Prof Dr Yip Cheng Har Consultant in General and Breast Surgery, UMMC |
| Paediatric clinical trial in Malaysia |
Dato’ Dr Jimmy Lee Kok Foo Head of CRC Terengganu |
| Medical device epidemiology & Malaysian statistics on medical device |
Mr. Zamane Abdul Rahman Director Medical Device Bureau MOH Chairman NMDS |
pdf 354kb
Print Friendly